Nemaura Medical Inc. (NMRD): What is Its Dividend Yield?


Nemaura Medical Inc. (NASDAQ:NMRD) saw an upside of 13.06% to $2.77 after adding $0.32 on Wednesday. The 5-day average trading volume is 128,677 shares of the company’s common stock. It has gained $3.25 in the past week and touched a new high 5 times within the past 5 days. An average of 38,074 shares of the company has been traded in the last 20 days, and the 50-day average volume stands at 18,382.

NMRD’s 1-month performance is 34.62% or $0.74 on its low of $1.68 reached on 01/13/23. The company’s shares have touched a 52-week low of $1.50 and high of $4.58, with the stock’s rally to the 52-week high happening on 01/25/23. YTD, NMRD has achieved 42.68% or $0.93 and has reached a new high 6 times. However, the current price is down -39.47% from the 52-week high price.

Will You Miss Out On This Growth Stock Boom?

A new megatrend in the fintech market is well underway. Mobile payments are projected to boom into a massive $12 trillion market by 2028. According to Motley Fool this growth stock could "deliver huge returns." Not only in the immediate future but also over the next decade. Especially since the man behind this company is a serial entrepreneur who has been wildly successful over the years.

And this is just one of our 5 Best Growth Stocks To Own For 2023.


Valuation Metrics

NMRD stock has a beta of 0.01. Moving on to other valuation ratios, the trailing price-to-sales (P/S) ratio is 83.71.

Nemaura Medical Inc.’s quick ratio for the period ended June 29 was 0.60, with the current ratio over the same period at 0.70. In terms of profitability, the gross margin trailing 12 months is 27.90%. The firm’s gross profit as reported stood at $0.16 million against revenue of $0.5 million.

Earnings Surprise

For the quarterly period ending June 29 this year, Net income grew 14.46% to -$4.08 million, while revenue of -$3.98 million was 2.45% off the previous quarter. Analysts expected NMRD to announce -$0.17 per share in earnings in its latest quarter, but it posted -$0.17, representing a 0.00% surprise. EBITDA for the quarter stood at more than $0.77 million. NMRD stock balance sheet for the quarter ending June 29 shows that total liabilities totaled 24.91 million, with total debt at $20.89 million. Shareholders hold equity totaling $24.1 million.

Let’s look briefly at Nemaura Medical Inc. (NMRD) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 24 January was 81.42% to suggest the stock is trending Overbought, with historical volatility in this time period at 117.37%.

The stock’s 5-day moving average is $2.18, reflecting a +53.18% or $0.92 change from its current price. NMRD is currently trading +38.51% above its 20-day SMA, +29.90% above its 100-day SMA. However, the stock’s current price level is away from the SMA50 by +12.20% and SMA200 by-37.13%.

Stochastic %K and %D was 66.51% and 66.58% and the average true range (ATR) pointed at 0.30. The RSI (14) points at 73.32%, while the 14-day stochastic is at 61.78% with the period’s ATR at 0.25. The stock’s 9-day MACD Oscillator is pointing at 0.41 and 0.46 on the 14-day charts.

Analyst Ratings

In the most recent analyst report for Nemaura Medical Inc. (NASDAQ: NMRD), H.C. Wainwright launched coverage with a Buy rating. Analysts offering their rating for NMRD stock have a consensus rating for the stock as Buy. Currently, 0 brokerage advisors rate NMRD as a “sell,”, while 0 advise that investors “Hold.” 0 analysts have rated the stock as underweight. 0 rates the stock as overweight while 3 have offered a “buy” rating.

What is NMRD’s price target for the next 12 months?

Analysts have a consensus price target ranging from a low of $7.50 and a high of $13.00, with their median price target at $8.00. Looking at these predictions, the average price target given by analysts is for Nemaura Medical Inc. (NMRD) stock is $9.50.


Please enter your comment!
Please enter your name here